EU countries continue to be divided over whether Russia’s Sputnik V vaccine should be added to Europe’s vaccination program. In Italy, some regions want to move on with ordering the vaccine from Moscow, while Germany and France seem not to be on the same page regarding the matter. The European Commission meanwhile insists that 70% of EU population could still be vaccinated by September without making use of the Russian vaccine.
EurActiv.com: EU countries still puzzled over Russia’s vaccine
A picture taken on Dec. 4, 2020, shows the production of Russia's Gam-COVID-Vac vaccine against the coronavirus disease (Covid-19) registered under trade name Sputnik V, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in coordination with the Russian Defense Ministry, at the facility of Russia's biotech company BIOCAD in Strelna outside Saint Petersburg.
